Redmile Group, LLC Annexon, Inc. Transaction History
Redmile Group, LLC
- $1.53 Billion
- Q3 2024
A detailed history of Redmile Group, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 6,427,462 shares of ANNX stock, worth $35.1 Million. This represents 2.49% of its overall portfolio holdings.
Number of Shares
6,427,462
Previous 6,427,462
-0.0%
Holding current value
$35.1 Million
Previous $31.5 Million
20.82%
% of portfolio
2.49%
Previous 2.05%
Shares
10 transactions
Others Institutions Holding ANNX
# of Institutions
146Shares Held
102MCall Options Held
178KPut Options Held
159K-
Bain Capital Life Sciences Investors, LLC Boston, MA8.45MShares$46.1 Million8.98% of portfolio
-
Satter Management Co., L.P.7.41MShares$40.4 Million76.44% of portfolio
-
Bvf Inc San Francisco, CA7MShares$38.2 Million1.32% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$36 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.33MShares$29.1 Million0.09% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $260M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...